Teva, Amneal Lose Opana ER Patent Fight Against Endo
A Delaware federal judge on Friday upheld the validity of an Endo Pharmaceuticals Inc. patent for its opioid painkiller Opana ER, shooting down arguments from Amneal Pharmaceuticals LLC and Teva Pharmaceuticals...To view the full article, register now.
Already a subscriber? Click here to view full article